<DOC>
	<DOCNO>NCT00769405</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy , leucovorin , fluorouracil , oxaliplatin , work different way stop growth tumor cell , either kill cell stop dividing . It yet know whether systemic chemotherapy effective without intraperitoneal chemohyperthermia treat patient peritoneal carcinomatosis colorectal cancer . PURPOSE : This randomized phase III trial study systemic chemotherapy see well work compare without intraperitoneal chemohyperthermia treat patient undergo surgery peritoneal carcinomatosis colorectal cancer .</brief_summary>
	<brief_title>Systemic Chemotherapy With Without Intraperitoneal Chemohyperthermia Treating Patients Undergoing Surgery Peritoneal Carcinomatosis From Colorectal Cancer</brief_title>
	<detailed_description>OBJECTIVES : Primary - Compare overall survival patient peritoneal carcinoma colorectal origin undergo complete surgical resection receive systemic chemotherapy versus without intraperitoneal chemohyperthermia . Secondary - Evaluate recurrence-free survival patient . - Evaluate treatment toxicity . - Determine morbidity surgical complication . - Determine prognostic factor survival . OUTLINE : This multicenter study . Patients stratify accord participate center , residual tumor status ( R0/R1 vs R2 ≤ 1 mm ) , prior regimen systemic chemotherapy ( first v ≥ second ) , preoperative systemic chemotherapy metastatic disease ( yes v ) . Patients randomize 1 2 treatment arm . All patient undergo maximal surgical resection tumor . - Arm I : Patients receive standard systemic chemotherapy comprise leucovorin calcium IV follow fluorouracil IV 30 minute . Systemic chemotherapy continue least 6 month ( and/or surgery ) . Patients must stop systemic chemotherapy least 1 month receive intraperitoneal chemohyperthermia ( CHIP ) . If bevacizumab give neoadjuvant therapy , systemic chemotherapy must discontinue 6 week begin CHIP . Patients undergo CHIP comprise oxaliplatin intraperitoneally surgery hyperthermia 30 minute . - Arm II : Patients undergo surgery receive standard systemic chemotherapy comprise leucovorin calcium IV follow fluorouracil IV 30 minute . Systemic chemotherapy continue least 6 month ( surgery ) . Tumor marker ( ACE CA 19-9 ) assess baseline , 1 month surgery , follow-up visit . After completion study therapy , patient follow 1 3 month , every 3 month 3 year , every 6 month 2 year .</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Calcium , Dietary</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<mesh_term>Levoleucovorin</mesh_term>
	<mesh_term>Leucovorin</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm colorectal cancer Peritoneal carcinoma extension ≤ 25 ( Sugarbaker Index ) ( determine intraoperatively ) Planning receive standard systemic chemotherapy Chemotherapy metastatic cancer initiate 3 month surgery No extraperitoneal metastasis , include liver lung metastasis No carcinomatosis origin besides colorectal , particular appendical carcinomatosis Macroscopically complete resection ( R1 ) surgical reduction tumor residual thickness ≤ 1 mm ( R2 ) possible PATIENT CHARACTERISTICS : WHO performance status 01 Life expectancy &gt; 12 week ANC ≥ 1,500/mm^3 Platelet count ≥ 100,000/mm^3 Total bilirubin ≤ 1.5 time upper limit normal ( ULN ) AST ALT ≤ 3 time ULN Alkaline phosphatase ≤ 3 time ULN Creatinine ≤ 1.25 time ULN Eligible surgery No peripheral neuropathy &gt; grade 3 Not pregnant nursing No cancer past 5 year except basal cell skin cancer carcinoma situ cervix No inability submit followup medical test geographical , social , psychological reason Affiliated social security program Not deprive liberty supervision PRIOR CONCURRENT THERAPY : See Disease Characteristics No prior chemohyperthermia No concurrent participation another study firstline therapy cancer</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>recurrent colon cancer</keyword>
	<keyword>stage IV colon cancer</keyword>
	<keyword>recurrent rectal cancer</keyword>
	<keyword>stage IV rectal cancer</keyword>
	<keyword>peritoneal carcinomatosis</keyword>
</DOC>